EUVIMEDEUVIMED entdecken
Crossref

Farnesiferol B and Kamolonol Isolated from Ferula assa-foetida are Potent BACE1 Inhibitors with Neuroprotective Effects

Jong Min Oh, Woong-Hee Shin, Bomi Kim, Eonmi Kim, Hyun Ju Son, Hoon Kim iD

Planta Medica · 01.12.2025 · 91 (15) · 933-942

DOI: 10.1055/a-2689-8035 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Planta Medica, erschienen am 01.12.2025. Verfasst von Jong Min Oh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, College of Pharmacy, Sunchon National University, Suncheon, Republic of Korea. Hauptthemen laut MEDLINE: Amyloid Precursor Protein Secretases, Neuroprotective Agents, Ferula, Aspartic Acid Endopeptidases. Die Arbeit nennt 50 Literaturangaben. Gefördert von: National Research Foundation of Korea (NRF) grant funded by Korean Government.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Five compounds were isolated from Ferula assa-foetida and their beta-secretase 1 inhibitory activities were evaluated. Farnesiferol B and kamolonol showed potent beta-secretase 1 inhibitory activity with IC50 values of 8.11 and 1.00 µM and competitive inhibition patterns against beta-secretase 1 with Ki values of 6.51 and 0.41 µM, respectively. In silico pharmacokinetics showed that farnesiferol B was predicted to have high gastrointestinal absorption and blood-brain barrier permeability. In cell studies, farnesiferol B and kamolonol were nontoxic to normal Madin-Darby canine kidney and neuroblastoma cells, and both showed protective effects on neuroblastoma cells for Aβ42-induced neurotoxicity. In molecular docking simulations, we found that the efficacy of the compounds may be related to their interaction with the flap region and hydrogen bonding with ARG368. In addition, molecular dynamics simulation of kamolonol showed the ligand maintained its stability in interaction with the loop residues. These results show that farnesiferol B and kamolonol are potent beta-secretase 1 inhibitors with neuroprotective effects, suggesting that they are potential candidates for the treatment of neurodegenerative disorders, such as Alzheimerʼs disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyloid Precursor Protein SecretasesNeuroprotective AgentsFerulaAspartic Acid EndopeptidasesAnimalsMolecular Docking SimulationDogsMadin Darby Canine Kidney CellsHumansCell Line, TumorMolecular Dynamics SimulationAmyloid beta-Peptides

Substanzen

Amyloid Precursor Protein SecretasesNeuroprotective AgentsAspartic Acid EndopeptidasesBACE1 protein, humanAmyloid beta-Peptides

Autor:innen und Institutionen

  • Department of Pharmacy, College of Pharmacy, Sunchon National University, Suncheon, Republic of Korea.
  • Korea Institute of Oriental Medicine, Naju, Republic of Korea.
  • Department of Biomedical Informatics, College of Medicine, Korea University, Seoul, Republic of Korea.
  • National Institute for Korean Medicine Development, Gyeongsan, Republic of Korea.

ORCID-Profile: Hoon Kim

Förderung

  • National Research Foundation of Korea (NRF) grant funded by Korean Government

Zitieren

APA

Oh, J. M., Shin, W. H., Kim, B., Kim, E., Son, H. J., & Kim, H. (2025). Farnesiferol B and Kamolonol Isolated from Ferula assa-foetida are Potent BACE1 Inhibitors with Neuroprotective Effects. Planta Medica, 91(15), 933-942. https://doi.org/10.1055/a-2689-8035

Vancouver

Oh JM, Shin WH, Kim B, Kim E, Son HJ, Kim H. Farnesiferol B and Kamolonol Isolated from Ferula assa-foetida are Potent BACE1 Inhibitors with Neuroprotective Effects. Planta Medica. 2025;91(15):933-942. doi:10.1055/a-2689-8035

BibTeX
@article{Oh2025,
  author = {Oh, Jong Min and Shin, Woong-Hee and Kim, Bomi and Kim, Eonmi and Son, Hyun Ju and Kim, Hoon},
  title = {Farnesiferol B and Kamolonol Isolated from Ferula assa-foetida are Potent BACE1 Inhibitors with Neuroprotective Effects},
  journal = {Planta Medica},
  year = {2025},
  volume = {91},
  number = {15},
  pages = {933--942},
  doi = {10.1055/a-2689-8035}
}
Kostenlos starten →